Business
It is no secret that Allergan has been in a war against Valeant Pharmaceuticals and activist investor Bill Ackman, who owns a stake in...
Hi, what are you looking for?
It is no secret that Allergan has been in a war against Valeant Pharmaceuticals and activist investor Bill Ackman, who owns a stake in...
Allergan, which has received a well-storied hostile takeover bid from Valeant Pharmaceutical, courtesy of hedge fund manager Bill Ackman is making acquisitions to show...
Bill Ackman, who has to do something huge to be in the press every single week or else he’ll get wrinkles and will need...
The following are the top five new positions or position increases in John Paulson’s portfolio: 1. Allergan (AGN) is the 3rd largest holding for...
Looking youthful for his mid-forties, Bill Ackman doesn’t seem to need Botox. So why is he so hot on the trail for Allergan, encouraging...
Fund manager John Paulson added a new position in controversial stock Allergan, which is the object of a hostile takeover bid by Valeant Pharmaceuticals....
Of course, one can always find ways to track buys and sells from guru hedge fund managers, but there are exchange traded funds that...
Bill Ackman, in his obsessive, Ahab-like quest to force Botox-maker Allergan (AGN) to acquiesce to a hostile $54 billion takeover bid from Valeant (VRX),...
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
Steven Mandel’s Greenwich, Connecticut-based Lone Pine Capital has 67 holdings worth $24.7 billion, and the fund’s value increased 1.08% in the second quarter. Mandel...